Combination of immunoglobulins and natural killer cells in the context of CMV and EBV infection.

Frenzel, K; Lehmann, J; Krüger, D H; Martin-Parras, L; Uharek, L; Hofmann, J

Frenzel, K; Lehmann, J; Krüger, D H; Martin-Parras, L; Uharek, L; Hofmann, J.

Affiliation

Frenzel K; Institute of Medical Virology, Helmut-Ruska-Haus, Charité University Medicine, Charitéplatz 1, 10117, Berlin, Germany.

Med Microbiol Immunol ; 203(2): 115-23, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24337366

Subject(s)

Cytomegalovirus Infections/immunology; Cytomegalovirus/immunology; Epstein-Barr Virus Infections/immunology; Herpesvirus 4, Human/immunology; Immunoglobulins/immunology; Killer Cells, Natural/immunology; Antibodies, Monoclonal/immunology; Antibodies, Viral/immunology; Antigens, Viral/immunology; Cells, Cultured; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins / Killer Cells, Natural / Cytomegalovirus Infections / Herpesvirus 4, Human / Epstein-Barr Virus Infections / Cytomegalovirus Limits: Humans Language: En Journal: Med Microbiol Immunol Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google